Preliminary new research discussed today at the American College of Neuropsychopharmacology’s Annual Meeting finds that oxytocin, when administered using intravenous fluid and nasal technology may have significant positive effects on adult autism patients.
A blind man suffering d?j? vu. It sounds like a contradiction in terms — but the first case study of its kind has turned the whole theory of d?j? vu on its head.
People with poor memory may face a higher risk of cardiovascular or heart-related diseases like heart attack or myocardial infarction, MI, revealed by researchers from the Edinburgh University.
For people unable to simultaneously rub their stomach while patting their head, a new twist may be at hand. Touch, rather than concentration, could let people multi-task with their hands, and this may also potentially help improve the performance of people with coordination problems, according to psychologists.
The veil of mystery surrounding our extinct hominid cousins, the Neanderthals, has been at least partially lifted to reveal surprising results. Scientists with the U.S. Department of Energy’s Lawrence Berkeley National Laboratory (Berkeley Lab) and the Joint Genome Institute (JGI) have sequenced genomic DNA from fossilized Neanderthal bones.
Results of the two largest studies on hyponatremia, SALT-1 and SALT-2, presented Nov. 14 at the American Heart Association’s Scientific Sessions in Chicago, found that the investigational drug tolvaptan treated hyponatremia ? water intoxication — faster and more effectively than available treatments.
As the prevalence of allergic rhinitis appears to be rising, there are increasing concerns about its impact on health, sleep, work and school performance, as well as unmet patient needs regarding its treatment according to experts presenting new data at the Annual Meeting of the American College of Allergy, Asthma and Immunology (ACAAI).
Researchers at the University of Illinois at Chicago College of Pharmacy are attempting to discover how genes determine how well an antipsychotic medication works in adults and children and the side effects it will cause.
For the first time, scientists at the Max Planck Institute for Neurobiology in Martinsried near Munich have been able to show how two nerve cells communicate with each other from different hemispheres in the visual center. This astoundingly simple circuit diagram could at a later date provide a model for algorithms to be deployed in technical systems (Nature Neuroscience, Oct. 10, 2006).
The developmental oral therapy FTY720 (fingolimod) has demonstrated sustained benefits over two years in patients suffering from relapsing multiple sclerosis (MS), indicating that it could provide an important new option for treating this disabling neurological disease estimated to affect more than 2.5 million people worldwide.